All Pharma News
Editas Q1 2024 Results Call, Investor Events

Editas Q1 2024 Results Call, Investor Events
GLOBENEWSWIRE
02 May 2024
Share Share
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
GLOBENEWSWIRE
01 May 2024
Share Share
Editas Preclinical In Vivo Pipeline Data At ASGCT Meeting

Editas Preclinical In Vivo Pipeline Data At ASGCT Meeting
GLOBENEWSWIRE
22 Apr 2024
Share Share
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results
GLOBENEWSWIRE
28 Feb 2024
Share Share
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results
GLOBENEWSWIRE
21 Feb 2024
Share Share
Editas Medicine to Participate in Upcoming Investor Conferences

Editas Medicine to Participate in Upcoming Investor Conferences
GLOBENEWSWIRE
31 Jan 2024
Share Share
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities
GLOBENEWSWIRE
08 Jan 2024
Share Share
Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GLOBENEWSWIRE
03 Jan 2024
Share Share
Vertex pays Editas $100M to use gene-editing tech

Vertex pays Editas $100M to use gene-editing tech
Gabrielle Masson FIERCE BIOTECH
13 Dec 2023
Share Share
Editas Announces New EDIT-301 Safety and Efficacy Data in 17 Patients Presented

Editas Announces New EDIT-301 Safety and Efficacy Data in 17 Patients Presented
GLOBENEWSWIRE
11 Dec 2023
Share Share